Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3987116
Max Phase: Preclinical
Molecular Formula: C50H57ClN6O8S
Molecular Weight: 937.56
Molecule Type: Small molecule
Associated Items:
ID: ALA3987116
Max Phase: Preclinical
Molecular Formula: C50H57ClN6O8S
Molecular Weight: 937.56
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3cc(OCCCN4CCCCC4)ccc3-c3ccc(Cl)cc3)CC2)cc1Oc1ccccc1
Standard InChI: InChI=1S/C50H57ClN6O8S/c51-40-12-10-38(11-13-40)45-18-15-43(64-29-7-24-54-22-5-2-6-23-54)32-39(45)36-55-25-27-56(28-26-55)41-14-17-46(49(33-41)65-42-8-3-1-4-9-42)50(58)53-66(61,62)44-16-19-47(48(34-44)57(59)60)52-35-37-20-30-63-31-21-37/h1,3-4,8-19,32-34,37,52H,2,5-7,20-31,35-36H2,(H,53,58)
Standard InChI Key: YINFYGDRRATERP-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 937.56 | Molecular Weight (Monoisotopic): 936.3647 | AlogP: 9.24 | #Rotatable Bonds: 18 |
Polar Surface Area: 155.82 | Molecular Species: ZWITTERION | HBA: 12 | HBD: 2 |
#RO5 Violations: 3 | HBA (Lipinski): 14 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 4.18 | CX Basic pKa: 9.25 | CX LogP: 7.93 | CX LogD: 7.20 |
Aromatic Rings: 5 | Heavy Atoms: 66 | QED Weighted: 0.05 | Np Likeness Score: -1.36 |
1. (2015) Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases, |
Source(1):